Left Menu
Development News Edition

Coronavirus: Health ministry restricts sale, distribution of hydroxychloroquine

PTI | New Delhi | Updated: 27-03-2020 10:51 IST | Created: 27-03-2020 10:51 IST
Coronavirus: Health ministry restricts sale, distribution of hydroxychloroquine

New Delhi, Mar 27 (PTI ) The Union health ministry has restricted the sale and distribution of 'hydroxychloroquine' stating it as an essential drug to meet the requirements of any emergency arising due to COVID-19 pandemic. The order issued on Thursday said that in public interest, it was necessary and expedient to regulate and restrict the sale and distribution of the drug and preparation based thereon for preventing misuse.

"The Central government is satisfied that the drug 'hydroxychloroquine' is essential to meet the requirements of emergency arising due to pandemic COVID-19 and in the public interest, it is necessary and expedient to regulate and restrict the sale and distribution of the drug and preparation based thereon for preventing their misuse," it said. "Now, therefore, in exercise of the powers conferred by Section 26B of the Drugs and Cosmetics Act, 1940 (23 of 1940), the Central Government hereby directs that sale by retail of any preparation containing the drug hydroxychloroquine shall be in accordance with the conditions for sale of drugs specified in Schedule H1 to the Drugs and Cosmetics Rules, 1945," it stated.

This order shall come into force on the date of its publication in the official gazette. ICMR has recommended the use of hydroxychloroquine  as a preventive medication for healthcare workers involved in the care of suspected or confirmed cases of COVID-19 and also asymptomatic household contacts of laboratory confirmed cases.

The treatment protocol recommended by the ICMR has been approved by the Drug Controller General of India (DGCI) for restricted use in emergency situations..

(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)

Download The Devdiscourse News App for Latest News.



Ayurveda for COVID 19: Professionals owe the responsibility to protect it from quacks and fake news

Indian Ayurveda professionals are lagging behind their foreign counterparts in handling quacks and protecting credentials of the Ayurveda at the time of COVID 19 pandemic. The professionals of Ayurveda cannot abjure the responsibility to co...

Education post-coronavirus: Schools to rush for more digitalization

Digital education would undoubtedly boom in the post-coronavirus world, supported by educational institutions that have discovered its efficiency during the crisis, but it is still not expected to outshine traditional classroom learning....

Public health care post-COVID 19 to go for revamping, not rebooting

Until now, the economies used to classify healthcare sector under social expenditure. However, the devastation caused by COVID 19 pandemic has upgraded public healthcare on topmost priority and core economic activity for controlling future ...

Coronavirus lockdowns to speed up long-pending revamping of supply chains

With millions of production lines impacted, business disruptions to some extent are unavoidable and the lessons learned from this turbulence will leave an everlasting impact on both global and local levels of supply chains....


Latest News

Rajasthan HC says no bail pleas should be listed during lockdown

The Rajasthan High Court directed the registry on Monday to not list any bail pleas as extremely urgent case as it had decided that only important matters would be taken up during the lockdown over the novel coronavirus pandemic. During a h...

Nageswara Rao joins Bank of Maharashtra as executive director

State-owned Bank of Maharashtra on Tuesday said Nageswara Rao Y has joined as its executive director. Rao was officer on special duty and whole time director at Syndicate Bank from April 15, 2019, BoM said in a statement.Prior to joining Sy...

RIL once again overtakes TCS to become the most valued firm

Reliance Industries Limited RIL on Tuesday surpassed TCS to grab the title of most valued firm by market capitalisation. At close of trade, the market capitalisation m-cap of RIL was Rs 7,05,211.81 crore, which was Rs 21,133.32 crore more t...

England's coronavirus death toll rises 29% to 1,651

The death toll in England from the coronavirus outbreak rose 29 to 1,651 with one person as young as 19 dying without any underlying health conditions, the National Health Service said.Patients were aged between 19 and 98 years old and all ...

Give Feedback